The US Food and Drug Administration (FDA) has made the decision to delay the active enforcement of the Drug Supply Chain Security Act (DSCSA), aimed at combatting the issue of counterfeit medicines entering the supply chain.

The new deadline for adding a product identifier to prescription drug packaging will now be in November 2018, however there is still concern that some CMOs will not meet the extended deadline.

DSCSA: There is still concern that some CMO's will not meet the extended deadline.

In this article with in-Pharma Technologist, our Director of Corporate Projects, Staffan Widengren discusses what companies should be focusing on in order to make the most of the extra time and ensure that a robust serialisation solution is in place before the new enforcement date.

Read the full article here: The-serialization-stragglers-industry-concern-for-complacency.

Learn more about the DSCA enforcement delay and what you need to know here.

Read the latest industry feedback as experts comment on the FDA's DSCSA serialisation extension here.